Table 4 Outcomes of TAE for sporadic and tuberous sclerosis-related AMLs
Sporadic | aTSC | ALL | P-value | |
|---|---|---|---|---|
bAMLs, n | 15 | 35 | 50 | |
Mean volume reduction rate, % (±SD) | 72.9 (±21.5) | 63.5 (±25.2) | 66.0 (±24.4) | 0.27 |
Regrowth, n (%) | 3 (20.0%) | 11 (31.4%) | 14 (28.0%) | 0.41 |
Aneurysm ≥5 mm before TAE, n (%) | 2 (13.3%) | 17 (48.6%) | 19 (38%) | 0.019 |
Aneurysm ≥5 mm after TAE, n (%) | 0 (0%) | 1 (2.9%) | 1 (2.0%) |